Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
Author:
Publisher
Informa UK Limited
Subject
Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science
Reference109 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Metastasis as an evolutionary process
3. Adoptive cell transfer: a clinical path to effective cancer immunotherapy
4. Cancer immunotherapy using checkpoint blockade
5. Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy;International Immunopharmacology;2024-12
2. Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis;Applied Mathematical Modelling;2024-10
3. Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
4. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09
5. Metal‐Dependent DNAzymes for Cell Surface Engineering and Intracellular Bioimaging;DNA Nanotechnology for Cell Research;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3